Host Pennie Power breaks down Ozempic's real costs versus the shocking thousand-dollar list price most people never pay. She analyzes insurance savings cards, uninsured options, long-term financial implications, and clinical cost-effectiveness data to reveal when this medication makes economic sense—and when it doesn't—for managing obesity and preventing expensive chronic conditions.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
続きを読む
一部表示
22 分